FDA escalates scrutiny of med‑spa drug supply chains
FDA intensifies scrutiny of counterfeit and compounded products in med‑spas, including its first DSCSA warning letter and action on botulinum toxin and GLP‑1 supply‑chain integrity.
The desk
How med spas are inspected and regulated, where the oversight gaps sit, and what recourse a patient actually has.
Delayed filler reactions can appear months after injection. New research reveals risk factors and regulatory gaps patients rarely hear about.
By MSNN Editorial
FDA intensifies scrutiny of counterfeit and compounded products in med‑spas, including its first DSCSA warning letter and action on botulinum toxin and GLP‑1 supply‑chain integrity.
Delayed filler complications can appear months or years after injection. New peer-reviewed research reveals the risks regulators and patients rarely discuss.
FDA issues first DSCSA warning letter to a Texas med‑spa after it dispensed more Botox units than it purchased, exposing supply‑chain transparency failures.
New research documents hyaluronic acid risks from granulomas to autoimmune reactions. Here's what peer-reviewed studies say before your next filler appointment.
Filler vascular occlusion can cause tissue death and vision loss. New peer-reviewed research reveals how often it happens and what treatments exist.
Filler granulomas are a serious, underreported complication. New research reveals what patients and providers need to know before any injection.
Filler granulomas are a serious, underreported complication. New research reveals what patients and providers need to know before any injection.
New research exposes serious filler complications—from vascular occlusion to autoimmune reactions. Learn what the science says before your next appointment.
New research exposes serious filler complications—from vascular occlusion to autoimmune reactions. Learn what the science says before your next appointment.
New research exposes MedSpa safety gaps in filler oversight, rare immune reactions, and vascular risks. Learn what patients should ask before any procedure.
New research exposes medspa safety gaps in filler oversight, rare immune reactions, and vascular emergencies. Learn what patients should ask before any procedure.
Filler safety risks are rising as oversight varies by state. Learn what the latest research reveals about complications, regulations, and provider training.
New studies reveal filler safety risks, patchwork state oversight, and rising complications. What patients and providers need to know now.